Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro.
about
HIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchInhibitors of human immunodeficiency virus type 1 reverse transcriptase target distinct phases of early reverse transcriptionThe human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein zinc ejection activity of disulfide benzamides and benzisothiazolones: correlation with anti-HIV and virucidal activitiesHuman immunodeficiency virus type 1 nucleocapsid protein can prevent self-priming of minus-strand strong stop DNA by promoting the annealing of short oligonucleotides to hairpin sequences.Zinc finger structures in the human immunodeficiency virus type 1 nucleocapsid protein facilitate efficient minus- and plus-strand transferInteraction of the human immunodeficiency virus type 1 nucleocapsid with actin.Actinomycin D inhibits human immunodeficiency virus type 1 minus-strand transfer in in vitro and endogenous reverse transcriptase assays.Structural determinants of murine leukemia virus reverse transcriptase that affect the frequency of template switchingMolecular requirements for human immunodeficiency virus type 1 plus-strand transfer: analysis in reconstituted and endogenous reverse transcription systems.Human immunodeficiency virus type 1 central DNA flap: dynamic terminal product of plus-strand displacement dna synthesis catalyzed by reverse transcriptase assisted by nucleocapsid protein.Quantitative analysis of mRNA amplification by in vitro transcription.Zinc finger domain of murine leukemia virus nucleocapsid protein enhances the rate of viral DNA synthesis in vivo.The leader of the HIV-1 RNA genome forms a compactly folded tertiary structureRNA aptamers directed to human immunodeficiency virus type 1 Gag polyprotein bind to the matrix and nucleocapsid domains and inhibit virus productionFunctional replacement of nucleocapsid flanking regions by heterologous counterparts with divergent primary sequences: effects of chimeric nucleocapsid on the retroviral replication cycle.Human immunodeficiency virus type 1 nucleocapsid zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA.Mapping the RNA binding sites for human immunodeficiency virus type-1 gag and NC proteins within the complete HIV-1 and -2 untranslated leader regions.Initiation complex dynamics direct the transitions between distinct phases of early HIV reverse transcription.Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription.Blocking premature reverse transcription fails to rescue the HIV-1 nucleocapsid-mutant replication defect.Requirements for efficient minus strand strong-stop DNA transfer in human immunodeficiency virus 1.Nucleocapsid protein annealing of a primer-template enhances (+)-strand DNA synthesis and fidelity by HIV-1 reverse transcriptase.Human immunodeficiency virus Type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA(Lys3) in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding siteHuman immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract.Role of Vif in human immunodeficiency virus type 1 reverse transcriptionHuman immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA.A genetic system to identify DNA polymerase beta mutator mutants.Molecular mechanisms by which human immunodeficiency virus type 1 integrase stimulates the early steps of reverse transcription.Discontinuous plus-strand DNA synthesis in human immunodeficiency virus type 1-infected cells and in a partially reconstituted cell-free systemStructure/function mapping of amino acids in the N-terminal zinc finger of the human immunodeficiency virus type 1 nucleocapsid protein: residues responsible for nucleic acid helix destabilizing activityIn vitro synthesis of long DNA products in reactions with HIV-RT and nucleocapsid protein.A new role for HIV nucleocapsid protein in modulating the specificity of plus strand priming.Nucleocapsid protein function in early infection processes.Variation of human immunodeficiency virus type-1 reverse transcriptase within the simian immunodeficiency virus genome of RT-SHIV.Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging.HIV-1 nucleocapsid protein and the secondary structure of the binary complex formed between tRNA(Lys.3) and viral RNA template play different roles during initiation of (-) strand DNA reverse transcription.The HIV-1 nucleocapsid protein recruits negatively charged lipids to ensure its optimal binding to lipid membranesRole of post-transcriptional modifications of primer tRNALys,3 in the fidelity and efficacy of plus strand DNA transfer during HIV-1 reverse transcription.Efficient initiation of HIV-1 reverse transcription in vitro. Requirement for RNA sequences downstream of the primer binding site abrogated by nucleocapsid protein-dependent primer-template interactions.The role of template-primer in protection of reverse transcriptase from thermal inactivation.
P2860
Q26746070-11AF0472-0BBE-44E9-BE04-45DACF04AEECQ28359887-3B189AC3-64BD-49E2-A632-3FF686000276Q28379466-D8EF4777-6E3B-4C33-ACD5-A28EA01AB32CQ33603932-49734F69-7802-49AF-9437-CB9A8C3AF7A9Q33604321-CDBA604D-950B-41D5-A843-4F88597C39E1Q33643700-61E226D1-4477-4864-8D1D-16DC89680DF7Q33783618-FC1E1462-A89A-405F-93F2-7D604175AE0AQ33809246-B3102CFD-1388-4542-9BE9-6847204C767DQ33813827-C24B45F4-EAC7-43EA-A727-39D6097719C3Q33838354-D1A60DBC-453E-4331-B458-E4E6CB29B023Q34280588-270D47FA-7D9C-43F3-9688-003707396281Q34343761-A0C9BECC-A192-41E6-90C8-A74CD36875B0Q34362436-AB0D2694-2E0B-4213-A33E-17951F218A59Q34457815-DF4D145A-9E67-421A-8C83-99D6F7063B36Q34461837-557F3CF9-6C5F-4E2D-893C-6456E95C172BQ34464770-A96B50C2-CA0C-432C-BED9-4AA9D6D1AA4EQ34673247-5949602C-9930-4EDF-AE41-E441893B37B0Q34684128-72C267A1-51BD-4C60-9103-5ABDAEBC400BQ34775658-68A6B86A-AAC4-40ED-ABB3-5A7303E5C327Q35122165-A3DB7E0D-2DA2-412F-A47C-F32EC0FC7ACCQ35592213-B2A4468C-41E5-4DCC-A3D2-921FF9B00185Q35705540-DC688872-8D3F-44A2-BB96-2AD9ADC4742CQ35865776-41B18DA4-131D-481E-8A8C-91C0915D7792Q35870861-85E0A309-1430-4C79-BEFD-504CC4C2B21FQ35873743-718627D0-D942-413C-A937-1394DB51D318Q35888060-6DB2F029-68C5-44A5-B2B8-53C1DEDC7F64Q35996194-25743C7C-FF7B-4DA4-B70A-F64B82D8EE1BQ36098878-73A61C48-AF84-4956-9B18-BA565268DA53Q36548782-AAAB3978-0CCE-4C2D-8AA0-8219B2F0E9A1Q36791048-C8FA15D2-3B58-4018-8737-D1F0E1850F26Q36804480-AA75A2DB-4ACD-4370-9520-274F879437A9Q37023748-978E5CB7-F3C3-446A-9EDB-7E1826BB521CQ37086413-0DC5B357-293C-4DD8-9177-D1D7546E2A1BQ37538534-7663F75D-529C-43A9-9C5A-433EED028625Q37583529-5512F180-CBB9-468B-94E6-11DB2282C887Q38295770-96A8A550-86A8-4428-A66A-9D1E877D9CC2Q38302959-692C7768-8BC0-4840-A53D-A0977F1AB128Q38328581-19A852AC-F172-4F94-9642-6D9332BCD6EDQ38358135-A241E0B8-D9E5-41C9-8B09-35E4F2DE57F8Q38364029-20FA9F85-E938-40AB-9868-F0090C2F25AF
P2860
Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Effect of human immunodeficien ...... anscriptase activity in vitro.
@en
type
label
Effect of human immunodeficien ...... anscriptase activity in vitro.
@en
prefLabel
Effect of human immunodeficien ...... anscriptase activity in vitro.
@en
P2093
P356
P1433
P1476
Effect of human immunodeficien ...... anscriptase activity in vitro.
@en
P2093
P304
P356
10.1021/BI951707E
P407
P577
1996-01-01T00:00:00Z